CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 110 filers reported holding CUREVAC N V in Q4 2021. The put-call ratio across all filers is 1.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,304 | -33.2% | 1,655 | +1.9% | 0.00% | -50.0% |
| Q2 2023 | $16,922 | +131.6% | 1,624 | +55.0% | 0.00% | +100.0% |
| Q1 2023 | $7,305 | +51.8% | 1,048 | +31.3% | 0.00% | 0.0% |
| Q4 2022 | $4,812 | +20.3% | 798 | +72.0% | 0.00% | 0.0% |
| Q3 2022 | $4,000 | +100.0% | 464 | +181.2% | 0.00% | – |
| Q2 2022 | $2,000 | -83.3% | 165 | -72.8% | 0.00% | -100.0% |
| Q1 2022 | $12,000 | 0.0% | 606 | +66.9% | 0.00% | 0.0% |
| Q4 2021 | $12,000 | – | 363 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,625,943 | $16,942,326 | 13.48% |
| RA Capital Management | 12,245,955 | $127,602,851 | 2.41% |
| Avidity Partners Management LP | 4,300,000 | $44,806,000 | 1.56% |
| Camber Capital Management LP | 1,462,500 | $15,239 | 0.50% |
| Eversept Partners, LP | 357,342 | $3,723,504 | 0.31% |
| Ghisallo Capital Management LLC | 100,000 | $1,042,000 | 0.12% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 226,134 | $2,356,316 | 0.08% |
| Green Alpha Advisors, LLC | 11,492 | $119,747 | 0.08% |
| Alyeska Investment Group, L.P. | 899,423 | $9,371,988 | 0.07% |
| Virtus ETF Advisers LLC | 10,692 | $111,411 | 0.07% |